Therapy Analysis & Statistics, March 2015

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

1-30 of about 2 800 reports

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Irritable Bowel Syndrome - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Irritable Bowel Syndrome - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Irritable Bowel Syndrome - Global Drug Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with ...

  • Industries : Pharmaceutical, Therapy
  • Countries : Europe, World
PharmaPoint: Rheumatoid Arthritis - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - 5EU Drug Forecast and Market Analysis to 2023

  • $ 6 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - 5EU Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Biopharmaceutical, Pharmaceutical, Biotechnology
  • Countries : Europe
PharmaPoint: Irritable Bowel Syndrome - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: Irritable Bowel Syndrome - 5EU Drug Forecast and Market Analysis to 2023

  • $ 6 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Irritable Bowel Syndrome - 5EU Drug Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered ...

  • Industries : Pharmaceutical, Therapy
  • Countries : Europe
Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • December 2014
  • by GBI Research

Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation Summary Large and Diverse Pipeline The liver cancer pipeline contains 238 products in active development, approximately ...

  • Industries : General Medicine and Specialty Medicine, Pathology
  • Countries : Europe
Renal Cell Carcinoma: KOL Insight

Renal Cell Carcinoma: KOL Insight

  • $ 6 695
  • Industry report
  • February 2015
  • by Firstword Pharma

Will new checkpoint inhibitors revive immunotherapy in RCC? Renal Cell Carcinoma: KOL Insight offers opinions of 12 leading US and European KOLs that present business-critical insights for branded pharma ...

  • Industries : Therapy
  • Countries : Europe
Diagnostics and Therapeutics for Autism Spectrum Disorders: Global Markets

Diagnostics and Therapeutics for Autism Spectrum Disorders: Global Markets

  • $ 6 650
  • Industry report
  • March 2015
  • by BCC Research

REPORT HIGHLIGHTS The global autism spectrum disorders (ASD) market was valued at $346.2 million in 2013 and $360.9 million in 2014. This market is expected to grow to $412.7 million by 2019, a compound ...

  • Industries : Therapy
  • Countries : World
Radiotherapy: Technologies and Global Markets

Radiotherapy: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • February 2015
  • by BCC Research

REPORT HIGHLIGHTS The radiation therapy market totaled $5.4 billion in 2013 and $5.8 billion in 2014. The market is expected to reach $8.1 billion in 2019, a compound annual growth rate(CAGR) of 6.7%. ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : World
Nonalcoholic Steatohepatitis: KOL Insight

Nonalcoholic Steatohepatitis: KOL Insight

  • $ 6 495
  • Industry report
  • March 2015
  • by Firstword Pharma

Why This Report is Essential Expect a revolution in the treatment of nonalcoholic steatohepatitis (NASH) as a number of new therapies compete to become the first approved treatment for a disease that ...

  • Industries : Therapy
  • Countries : United States
A Competitive Analysis of the Global Breast Cancer Therapeutics Market : A New Class of Targeted Therapeutics Offers Novel Treatment Modalities to Treat Difficult Breast Cancers

A Competitive Analysis of the Global Breast Cancer Therapeutics Market : A New Class of Targeted Therapeutics Offers Novel Treatment Modalities to Treat Difficult Breast Cancers

  • $ 5 000
  • Industry report
  • March 2015
  • by Frost & Sullivan

Executive Summary •The global breast cancer therapeutics market is divided into x segments: hormonal therapy, targeted therapy, chemotherapy, and other therapy (for example, novel drugs in development). ...

  • Industries : Therapy
Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics

Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics

  • $ 4 995
  • Industry report
  • January 2015
  • by GBI Research

Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics Summary GBI Research, the leading business intelligence provider, ...

  • Industries : Pharmaceutical, Pathology, Therapy, General Medicine and Specialty Medicine, Healthcare
  • Countries : World, Europe
PharmaPoint: Rheumatoid Arthritis - US Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - US Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - US Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical
  • Countries : United States
PharmaPoint: Rheumatoid Arthritis - China Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - China Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - China Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical, Biopharmaceutical
  • Countries : China, Asia
PharmaPoint: Irritable Bowel Syndrome - US Drug Forecast and Market Analysis to 2023

PharmaPoint: Irritable Bowel Syndrome - US Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Irritable Bowel Syndrome - US Drug Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered ...

  • Industries : Pharmaceutical
  • Countries : Japan, World
PharmaPoint: Irritable Bowel Syndrome - Japan Drug Forecast and Market Analysis to 2023

PharmaPoint: Irritable Bowel Syndrome - Japan Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Irritable Bowel Syndrome - Japan Drug Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with ...

  • Industries : Pharmaceutical
  • Countries : Japan
Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth

Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth

  • $ 4 995
  • Industry report
  • December 2014
  • by GBI Research

Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth Summary Increasingly Crowded Market for Second-Line Therapies Improving Treatment Options for Moderate-to-Severe Rheumatoid ...

  • Industries : Pharmaceutical, Pathology
  • Countries : World
World Radiation Therapy Equipment Industry

World Radiation Therapy Equipment Industry

  • $ 4 950
  • Industry report
  • January 2015
  • by Global Industry Analysts

This report analyzes the worldwide markets for Radiation Therapy Equipment in US$ Million by the following Product Segments: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator. ...

  • Industries : Therapy
  • Countries : World, Japan, Europe
Human Papillomavirus (By Drug Class and Applications) and Cytomegalovirus (By Drug Type and Applications) Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020

Human Papillomavirus (By Drug Class and Applications) and Cytomegalovirus (By Drug Type and Applications) Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020

  • $ 4 795
  • Industry report
  • January 2015
  • by Transparency Market Research

Human papillomavirus (HPV) and Cytomegalovirus (CMV) therapeutics market report studies current as well as future prospects of the market on a global scale. The global market for HPV therapeutics is segmented ...

  • Industries : Therapy
  • Countries : World
Global Depression Therapy & Treatment Market – Depression drugs and devices, Anxiety Disorders,  SSRIs, Fischer wallace stimulator, Transcranial magnetic stimulation, Psychoanalysis, Cognitive Behavior, Psychodynamic, Electroconvulsive Pipeline Analysis,

Global Depression Therapy & Treatment Market – Depression drugs and devices, Anxiety Disorders,  SSRIs, Fischer wallace stimulator, Transcranial magnetic stimulation, Psychoanalysis, Cognitive Behavior, Psychodynamic, Electroconvulsive Pipeline Analysis,

  • $ 4 000
  • Industry report
  • January 2015
  • by Occams

Depression is a state of emotion that affects thoughts, actions and often, sleeping patterns of affected individual. Depression affects behavior in terms of loss of appetite, being in a constant state ...

  • Industries : Therapy, Pathology
  • Countries : World
Gene Therapy Oncology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

Gene Therapy Oncology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

  • $ 3 500
  • Industry report
  • January 2015
  • by Delve Insight

Summary DelveInsight’s Report: Gene Therapy Oncology Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene ...

  • Industries : Biological Therapy
Eluxadoline (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023

Eluxadoline (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Eluxadoline (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel ...

  • Industries : Pharmaceutical
  • Countries : World, Japan
Ibodutant (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023

Ibodutant (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Ibodutant (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel ...

  • Industries : Pharmaceutical
  • Countries : World, Japan
Xifaxan (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023

Xifaxan (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Xifaxan (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel ...

  • Industries : Pharmaceutical
  • Countries : World
Plecanatide (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023

Plecanatide (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Plecanatide (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel ...

  • Industries : Pharmaceutical
  • Countries : World, Japan
Tenapanor (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023

Tenapanor (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Tenapanor (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel ...

  • Industries : Pharmaceutical
  • Countries : World, Japan
Global Small Cell Lung Cancer Therapeutics Market 2015-2019

Global Small Cell Lung Cancer Therapeutics Market 2015-2019

  • $ 3 000
  • Industry report
  • March 2015
  • by Infiniti Research Limited

About Small Cell Lung Cancer Cancer occurs when, after cell transformation, normal cells grow and multiply without control. Lung cancer is a common cause of mortality and morbidity in developed and developing ...

  • Industries : Therapy, Pathology
  • Countries : World
HER-2 Positive Breast Cancer Market in the US 2015-2019

HER-2 Positive Breast Cancer Market in the US 2015-2019

  • $ 3 000
  • Industry report
  • March 2015
  • by Infiniti Research Limited

About HER-2 Positive Breast Cancer Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer in ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical, Healthcare
  • Countries : United States
Global Acquired Orphan Blood Diseases Therapeutics Market 2015-2019

Global Acquired Orphan Blood Diseases Therapeutics Market 2015-2019

  • $ 3 000
  • Industry report
  • March 2015
  • by Infiniti Research Limited

About Acquired Orphan Blood Diseases Therapeutics Acquired orphan blood diseases are rare disorders and are characterized by the body's inability to produce a sufficient amount of RBCs. This is basically ...

  • Industries : Pathology, Therapy
  • Countries : World
Global HER-2 Positive Breast Cancer Market 2015-2019

Global HER-2 Positive Breast Cancer Market 2015-2019

  • $ 3 000
  • Industry report
  • March 2015
  • by Infiniti Research Limited

About HER-2 Positive Breast Cancer Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer in ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical, Healthcare
  • Countries : World
Global Psoriasis Therapeutics Market 2015-2019

Global Psoriasis Therapeutics Market 2015-2019

  • $ 3 000
  • Industry report
  • December 2014
  • by Infiniti Research Limited

About Psoriasis and Its Types Psoriasis is a common immune-mediated disease of the skin. In psoriasis, the skin grows fast and causes buildup of thick white, red, or silvery patches of skin. It alters ...

  • Industries : Pathology, Pharmaceutical
  • Countries : World
Women’s Health - Assessing the Need for a Targeted and Specialized Approach

Women’s Health - Assessing the Need for a Targeted and Specialized Approach

  • $ 2 995
  • Industry report
  • January 2015
  • by CBR Pharma Insights

Women’s Health - Assessing the Need for a Targeted and Specialized Approach Summary Many of the diseases and conditions that affect mainly women are interlinked with similar root causes; however, placing ...

  • Industries : Pathology

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.